871 related articles for article (PubMed ID: 19545988)
1. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
Holub BJ
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids from fish oils and cardiovascular disease.
Holub DJ; Holub BJ
Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
4. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease prevention and treatment.
von Schacky C
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):193-8. PubMed ID: 19520557
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
7. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acids and cardiovascular disease.
von Schacky C
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):129-35. PubMed ID: 17284999
[TBL] [Abstract][Full Text] [Related]
9. Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors.
Ryan AS; Keske MA; Hoffman JP; Nelson EB
Am J Ther; 2009; 16(2):183-92. PubMed ID: 19145206
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie CJ; Milani RV; Mehra MR; Ventura HO
J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
[TBL] [Abstract][Full Text] [Related]
11. Dietary reference intakes for DHA and EPA.
Kris-Etherton PM; Grieger JA; Etherton TD
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):99-104. PubMed ID: 19525100
[TBL] [Abstract][Full Text] [Related]
12. Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".
Rupp H; Rupp TP; Wagner D; Alter P; Maisch B
Herz; 2006 Dec; 31 Suppl 3():30-49. PubMed ID: 17575804
[TBL] [Abstract][Full Text] [Related]
13. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels.
Agren JJ; Hänninen O; Julkunen A; Fogelholm L; Vidgren H; Schwab U; Pynnönen O; Uusitupa M
Eur J Clin Nutr; 1996 Nov; 50(11):765-71. PubMed ID: 8933125
[TBL] [Abstract][Full Text] [Related]
14. What can we expect from omega-3 fatty acids?
Chan EJ; Cho L
Cleve Clin J Med; 2009 Apr; 76(4):245-51. PubMed ID: 19339640
[TBL] [Abstract][Full Text] [Related]
15. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL; Mensink RP
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of Atlantic salmon in the Chinese diet reduces cardiovascular disease risk markers in dyslipidemic adult men.
Zhang J; Wang C; Li L; Man Q; Song P; Meng L; Du ZY; Frøyland L
Nutr Res; 2010 Jul; 30(7):447-54. PubMed ID: 20797476
[TBL] [Abstract][Full Text] [Related]
17. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
[TBL] [Abstract][Full Text] [Related]
18. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review.
Weber P; Raederstorff D
Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):28-37. PubMed ID: 10812585
[TBL] [Abstract][Full Text] [Related]
19. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
Rupp H
Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
[TBL] [Abstract][Full Text] [Related]
20. Assessing the environment for regulatory change for eicosapentaenoic acid and docosahexaenoic acid nutrition labeling.
Brownawell AM; Harris WS; Hibbeln JR; Klurfeld DM; Newton I; Yates A
Nutr Rev; 2009 Jul; 67(7):391-7. PubMed ID: 19566599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
